9 Minutes for Tandem Colonoscopy Withdrawal

Sponsor
Changhai Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04797065
Collaborator
No.85 Hospital, Changning, Shanghai, China (Other), Yantaishan Hospital of Yantai City, Yantai, China (Other), Seventh Medical Center of PLA Army General Hospital (Other), The First Affiliated Hospital of Dalian Medical University (Other), The First Affiliated Hospital of the Medical College, Shihezi University (Other), Shanghai 8th People's Hospital (Other), Shanxi Provincial People's Hospital (Other), Qinghai People's Hospital (Other), Leqing People's Hospital (Other), Affiliated Hospital of North Sichuan Medical College (Other), Zhejiang University (Other), Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine (Other), The General Hospital of Eastern Theater Command (Other), Heilongjiang provincial hospital (Other), The Second Hospital of Hebei Medical University (Other)
733
1
2
9.2
80

Study Details

Study Description

Brief Summary

A mean withdrawal time of at least 6 minutes has been considered to be one of the critical quality criterions of colonoscopy. Recently, our group completed a multicenter randomized controlled trial, which proved that prolonging the withdrawal time to 9 minutes could significantly improve the adenoma detection rate of colonoscopists, especially for young colonoscopists and proximal colon. However, it has some limitations in included participates (mixed indications for colonoscopy) and cannot illustrate the impact of withdrawal time on adenoma miss rate in a parallel randomized design. It is necessary to include tandem colonoscopy and adopt strict criteria of the screening population to confirm the effect of the 9-minute withdrawal time on the adenoma miss rate. Therefore, the investigators plan to conduct a multicenter, randomized controlled trial of tandem colonoscopy to compare adenoma miss rate of 6-minute and 9-minute withdrawal in screening population.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 6-minute then 9-minute withdrawal
  • Procedure: 9-minute then 6-minute withdrawal
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
733 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Diagnostic
Official Title:
Impact of 9-minute Withdrawal Time on Adenoma Miss Rate: A Multicenter, Prospective, Randomized Controlled Trial of Tandem Colonoscopy
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Nov 5, 2021
Actual Study Completion Date :
Dec 5, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: 6-minute then 9-minute withdrawal

Patients in 6-minute then 9-minute withdrawal group will first be carefully observed in 6 minutes then in 9 minutes during the segmental withdrawal. At 6-minute withdrawal, the left colon, transverse colon and right colon will take 2 minutes each. Then at 9-minute withdrawal, the observation of the left colon, transverse colon and the right colon will be maintained for 3 minutes each. A stop watch will be utilized to remind endoscopists the withdrawal time. The time to perform polyp biopsy will not be included.

Procedure: 6-minute then 9-minute withdrawal
Patients in 6-minute then 9-minute withdrawal group will first be carefully observed in 2 minutes then in 3 minutes during each colonic segment. In actual performance, withdrawal of the right colon, transverse colon and the left colon can be operated in segmental tandem colonoscopy. Taking the right colon as an example, after the endoscope reaches the cecum, it can be withdrawn to the splenic curvature in 2 minutes, then reentered the cecum and withdrawn to the splenic curvature in 3 minutes.

Active Comparator: 9-minute then 6-minute withdrawal

Patients in 9-minute then 6-minute withdrawal group will first be carefully observed in 9 minutes then in 6 minutes during the segmental withdrawal. At 9-minute withdrawal, the left colon, transverse colon and right colon will take 3 minutes each. Then at 6-minute withdrawal, the observation of the left colon, transverse colon and the right colon will be maintained for 2 minutes each. A stop watch will be utilized to remind endoscopists the withdrawal time. The time to perform polyp biopsy will not be included.

Procedure: 9-minute then 6-minute withdrawal
Patients in 9-minute then 6-minute withdrawal group will first be carefully observed in 3 minutes then in 2 minutes during each colonic segment. In actual performance, withdrawal of the right colon, transverse colon and the left colon can be operated in segmental tandem colonoscopy. Taking the right colon as an example, after the endoscope reaches the cecum, it can be withdrawn to the splenic curvature in 3 minutes, then reentered the cecum and withdrawn to the splenic curvature in 2 minutes.

Outcome Measures

Primary Outcome Measures

  1. adenoma miss rate(AMR) [60 minutes]

    Adenomas detected in the second-pass examination were defined as missed adenomas; the AMR was defined as follows: number of adenomas detected in the second-pass examination/total number of adenomas detected in the two pass.

Secondary Outcome Measures

  1. advanced adenoma miss rate(AAMR) [60 minutes]

    AAMR is the number of advanced adenomas detected in the second-pass examination/total number of advanced adenomas detected in the two pass.

  2. adenoma detection rate(ADR) [60 minutes]

    ADR is the number of patients with at least one adenoma, divided by the total number of patients.

  3. adenomas per colonoscopy(APC) [60 minutes]

    APC was calculated as the number of adenomas detected during colonoscopy withdraw divided by the number of colonoscopies.

  4. patient-level AMR(pAMR) [60 minutes]

    the number of participants with adenomas detected only during the second-pass colonoscopy divided by the total number of participants with adenomas detected during the tandem colonoscopy

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients whose age is between 40-75.

  • Patients who have indications for screening

  • Patients who have signed inform consent form.

Exclusion Criteria:
  • Patients who have undergone colonic resection or polypectomy

  • Patients with alarming signs and symptoms of colorectal cancer: hematochezia, melena, anemia, weight loss, abdominal mass, positive digital rectal examination

  • Patients with abnormal blood coagulation or taking antiplatelets or anticoagulants within 7 days

  • Patients with inflammatory bowel diseases

  • Patients with a history of abdominal surgery, or highly suspected or confirmed colorectal cancers by radiographic and laboratory tests

  • Patients with hereditary colorectal cancer syndrome (including familial adenomatous polyposis).

  • Patients with pregnancy, severe chronic cardiopulmonary and renal disease.

  • Patients with failed cecal intubation

  • Patients with poor BPQ that necessitated a second bowel preparation

  • Patients with therapeutic colonoscopy for existing lesions

  • Patients refusing to participate or to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Changhai Hospital, Second Military Medical University Shanghai China 200433

Sponsors and Collaborators

  • Changhai Hospital
  • No.85 Hospital, Changning, Shanghai, China
  • Yantaishan Hospital of Yantai City, Yantai, China
  • Seventh Medical Center of PLA Army General Hospital
  • The First Affiliated Hospital of Dalian Medical University
  • The First Affiliated Hospital of the Medical College, Shihezi University
  • Shanghai 8th People's Hospital
  • Shanxi Provincial People's Hospital
  • Qinghai People's Hospital
  • Leqing People's Hospital
  • Affiliated Hospital of North Sichuan Medical College
  • Zhejiang University
  • Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine
  • The General Hospital of Eastern Theater Command
  • Heilongjiang provincial hospital
  • The Second Hospital of Hebei Medical University

Investigators

  • Principal Investigator: Zhaoshen Li, M.D, Changhai Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Zhaoshen Li, Director of Gastroenterology Dept, Changhai Hospital
ClinicalTrials.gov Identifier:
NCT04797065
Other Study ID Numbers:
  • withdrawal time-2
First Posted:
Mar 15, 2021
Last Update Posted:
Feb 1, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zhaoshen Li, Director of Gastroenterology Dept, Changhai Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2022